Anticompetitive actions taken by one firm only

Abstract

Since branded drug companies lose market shares and monopoly profits when competitors enter, innovators tend to prevent competition to extend their monopoly power. As Bennato and Valletti (2014: 83) claim in their paper, monopoly power is gained through patent protection. Correspondingly, it is especially in the interest of originator companies to keep their monopoly power by extending patent protection and detain competition.